WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Website Revenue Monday, October 21, 2019 
Add Press Release News | News Feeds Feeds | Email This News Email


Molecular Therapy Impact Factors Jump Nearly 28 Percent Across Family of Titles
Wednesday, June 26, 2019

Parent journal, Molecular Therapy, now tops the field with a 19.9 percent jump in impact factor to 8.402.

MILWAUKEE, June 26, 2019 /PRNewswire-PRWeb/ -- The latest impact factor scores for the Molecular Therapy family of journals, the official journals of the American Society of Gene & Cell Therapy (ASGCT), rose by a collective average of 27.9 percent when released on Thursday, June 20.

Impact factors, which measure the frequency with which an average article has been cited in a journal, rank research titles against one another to determine leading journals around the world.

The impact factor of Molecular Therapy, ASGCT's first and primary journal, rose 19.9 percent to 8.402 and remains the top journal in the field. Elsewhere in the Molecular Therapy family, Molecular Therapy-Oncolytics and Molecular Therapy-Methods & Clinical Development earned the largest percentage increases (54.7 and 32.4 percent, respectively) across publisher Cell Press' entire portfolio. Oncolytics also jumped 48 places in overall rank in the Oncology category, from a rank of 85 to 37. The Molecular Therapy family of journals are now the top-ranked journals in the field.

Overall growth in the Molecular Therapy family of journals are as follows:

    --  Molecular Therapy: 8.402 (+19.9 percent)
    --  Molecular Therapy-Nucleic Acids: 5.919 (+4.6 percent)
    --  Molecular Therapy-Oncolytics: 5.71 (+54.7 percent)
    --  Molecular Therapy-Methods & Clinical Development: 4.875 (+32.4 percent)

About ASGCT
The American Society of Gene & Cell Therapy is the primary professional membership organization for scientists, physicians, patient advocates, and other professionals with interest in gene and cell therapy. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, biotechnology and pharmaceutical companies. ASGCT advances knowledge, awareness, and education leading to the discovery and clinical application of gene and cell therapies to alleviate human disease to benefit patients and society.

SOURCE Molecular Therapy



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav Automated check-out start-up IMAGR partners with major Japanese retailer | Oct 21, 2019
Nav Boundless Immigration Launches Public Charge Risk Estimator | Oct 21, 2019
Nav AInnovation Selected as a 2019 Red Herring Top 100 Asia Winner | Oct 21, 2019
Nav SalesHood Launches PartnerHood To Scale Coaching and Content for Partners | Oct 21, 2019
Nav Rewind Offers Free Holiday Data Backups for E-Commerce Platforms | Oct 21, 2019
Nav Vena's Fan-Favorite vCommute Case Launched for the New Google Pixel 4 and Pixel 4 XL | Oct 21, 2019
Nav Shoe Swapping Arrives in Los Angeles | Oct 21, 2019
Nav Global Luxury Watch Market Report 2019-2023: Growing Demand for Second-hand Luxury Watches | Oct 21, 2019
Nav Mazooma Makes iGaming and Sports Wagering Payments Easier with Launch of eCheck Select Xpress | Oct 21, 2019
Nav Princeton University Press and RBmedia Announce Exclusive Audiobook Publishing Partnership | Oct 21, 2019
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News